Log In
Print
BCIQ
Print
Print this Print this
 

Gralise, gabapentin

Also known as: DM-1796 (formerly Gabapentin GR)

  Manage Alerts
Collapse Summary General Information
Company Depomed Inc.
DescriptionOnce-daily formulation of gabapentin using Acuform delivery technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationNeuralgia
Indication DetailsTreat post-herpetic neuralgia (PHN)
Regulatory Designation

U.S. - Orphan Drug (Treat post-herpetic neuralgia (PHN))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today